These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension. Jordan J; Yumuk V; Schlaich M; Nilsson PM; Zahorska-Markiewicz B; Grassi G; Schmieder RE; Engeli S; Finer N J Hypertens; 2012 Jun; 30(6):1047-55. PubMed ID: 22573071 [TBL] [Abstract][Full Text] [Related]
4. Panel discussion: the potential for preventing disease associated with hypertension. Lovell RR; Doyle AE; McCall M; Stephens WB; Leighton P Med J Aust; 1973 Aug; 2(1):Suppl:15-8. PubMed ID: 4791237 [No Abstract] [Full Text] [Related]
5. [Skibinski coefficent in patients with hypertension and associated obesity]. Drozdov DD; Butkevich GA; Shimelis IV Vrach Delo; 1978 May; (5):38-40. PubMed ID: 676269 [No Abstract] [Full Text] [Related]
6. [Obesity and arterial hypertension in reference to the analysis of individual cases]. Borojev A Med Pregl; 1966; 19(11):535-9. PubMed ID: 5988663 [No Abstract] [Full Text] [Related]
7. [Arterial hypertension and obesity]. Tomasević M; Marjanović A; Basić H Med Arh; 1979; 33(2):139-40. PubMed ID: 542028 [No Abstract] [Full Text] [Related]
9. [Treatment of hypertension associated with metabolic anomalies]. Mancini M; Strazzullo P; Ferrara LA; Barba G Cardiologia; 1988 Dec; 33(12):1157-62. PubMed ID: 3076522 [No Abstract] [Full Text] [Related]
10. [Present status in pathogenesis, diagnosis and therapy of arterial hypertension]. Negoita CJ G Clin Med; 1972 Oct; 53(10):475-93. PubMed ID: 4666323 [No Abstract] [Full Text] [Related]
11. European Society of Hypertension Working Group on Obesity Antihypertensive effects of weight loss: myth or reality? Straznicky N; Grassi G; Esler M; Lambert G; Dixon J; Lambert E; Jordan J; Schlaich M; ; J Hypertens; 2010 Apr; 28(4):637-43. PubMed ID: 20125037 [No Abstract] [Full Text] [Related]
12. [Use of visken in hypertension associated with ischemic heart disease and nutritional obesity]. Khomenko VL; Vasiuk IuA; Romashkin AV; Sivkov SI; Mel'nikov AIu; Buskin VD Sov Med; 1990; (3):64-7. PubMed ID: 2195673 [No Abstract] [Full Text] [Related]
13. [Arterial hypertension - the specific case]. Weisser B; Düsing R; Mengden T Dtsch Med Wochenschr; 2001 Nov; 126(44):1235. PubMed ID: 11687982 [No Abstract] [Full Text] [Related]
14. Antihypertensive therapy in the obese hypertensive patient. Chrostowska M; Szczech R; Narkiewicz K Curr Opin Nephrol Hypertens; 2006 Sep; 15(5):487-92. PubMed ID: 16914960 [TBL] [Abstract][Full Text] [Related]
15. A case of moderate hypertension: diagnosis, management and consideration of family factors. Shires DB; Abbott C; MacLachlan R; Curtis D; Myhre D; Muzzerall L Can Med Assoc J; 1983 Mar; 128(5):535-7. PubMed ID: 6130833 [No Abstract] [Full Text] [Related]
18. [Characteristics of hemodynamics in ischemic stroke in patients with arterial hypertension and obesity]. Vinichuk Sm Klin Med (Mosk); 1987 Apr; 65(4):40-4. PubMed ID: 3599854 [No Abstract] [Full Text] [Related]
19. [Arterial hypertension and obesity]. Velásquez-Jones L Bol Med Hosp Infant Mex; 1990 Mar; 47(3):139-41. PubMed ID: 2193650 [No Abstract] [Full Text] [Related]
20. [Diabetes, arterial hypertension and obesity as factors of death risk in myocardial infarct]. Kutarski A; Bednarzewski J Pol Tyg Lek; 1976 May; 31(17):707-9. PubMed ID: 934939 [No Abstract] [Full Text] [Related] [Next] [New Search]